Raising the standard of care in women’s health
Our innovative solutions are designed to reduce preventable risk, improve clinical decision-making, and support more informed care for women.
Raising the standard of care in women’s health
Our innovative solutions are designed to reduce preventable risk, improve clinical decision-making, and support more informed care for women.
On a mission to reduce preventable injury:
(1)RACS 2021; MarketsandMarkets 2021, Laparoscopic Instruments Market — Global Forecast to 2026, March 2021. (2)StatPearls 2023, Ureteral Injury, StatPearls Publishing, NCBI Bookshelf, viewed June 2026. (3)MarketsandMarkets 2021.
Advancing safer, smarter care for women
We are advancing women’s health through clinically informed innovation, surgeon-led expertise and patent-protected medical device technology.
Founded by experienced surgeons and Gynaecologists, the company is developing medical devices and digital care solutions designed to reduce preventable surgical risk, improve outcomes for patients and support access to appropriate treatment pathways sooner.
Solutions to ease healthcare system costs
Beyond the immediate impact on patients, surgical complications can contribute to extended hospital stays, additional procedures, claims exposure, insurance costs, workforce pressure and increased demand on already stretched surgical resources.
Seabas Medical Technologies aims to support hospitals and healthcare systems with clinically-led technology that reduces avoidable risk, improves procedural safety and supports better use of healthcare resources.
(4)McCarus, SD et al. 2024, ‘Long-term economic outcomes of ureteral injury in the United States’, Current Medical Research and Opinion, 40(2), 325–333, https://doi.org/10.1080/03007995.2023.2283204. (5)Regenbogen, SE et al. 2016, ‘Hospital and payer costs associated with surgical complications’, JAMA Surgery, 151(9), 823–830, https://pubmed.ncbi.nlm.nih.gov/27168356. (6)RACS 2021; MarketsandMarkets 2021; McCarus et al. 2024; Regenbogen et al. 2016.
Minimising risk to maximise outcomes
Our patent-protected innovation Endoguard™ aims to address preventable risks and costs associated with complications and injury during laparoscopic procedures. Designed by experienced surgeons, the device is being developed to support safer surgical practice by responding to a known and under-addressed challenge in invasive surgery.
Clinically-led innovation in women’s health
With patent-protected medical device technology designed to reduce the risk of organ injury during gynaecological laparoscopic surgery, Seabas Medical Technologies is focused on an under-addressed area of preventable harm with meaningful relevance for patients, surgeons, hospitals, insurers and healthcare systems.